Key Takeaways Current GLP-1 weight-loss meds need to be taken as injections, but new trial results suggest a GLP-1 in pill form could be nearIn an 18-month clinical trial, people with obesity and diabetes lost more than 10% of their starting weight after taking oral orforglipronA researcher in the trial said that the drug could also be a cheaper

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly injection has been shown to be as effective as Mounjaro – but patients

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their waistlines.

A WEIGHT loss pill set to be available next year will be a cheaper, easier and effective alternative to Mounjaro injections, say experts. They hope orforglipron will “open the door to treatment

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Researchers found benefits including reduced blood pressure were reversed after patients ceased taking the jab

Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer rates are high.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also known as GLP-1 and GIP injections — can help when ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly traded company in health care to hit the milestone.

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such as Wegovy or Mounjaro, but stopped just before pregnancy or in the